SF0121 significantly expands the scope of practice for pharmacists, including lowering the minimum age for pharmacist-administered immunizations to as young as three years old and broadening pharmacists’ authority to assess patients and initiate care under board rules. While pharmacists play an important role in healthcare access, this bill moves clinical decision-making further away from physicians and pediatric providers who are specifically trained to evaluate young children’s full medical history and developmental needs. 

Lowering the immunization age raises concerns about patient safety, continuity of care, and parental understanding of medical risks and benefits in complex pediatric cases. It also shifts sensitive healthcare decisions into retail settings that may not be equipped to manage complications or provide comprehensive follow-up.

There are also concerns about financial incentives in high-volume retail pharmacy settings, where increased vaccination volume can be tied to reimbursement structures, creating pressure to give more shots to more patients rather than prioritize individualized medical judgment.

Finally, the bill hands broad authority to the Board of Pharmacy through rulemaking, reducing legislative oversight over major changes to healthcare policy. In short, SF0121 expands scope of practice and lowers age thresholds without sufficient safeguards, risking fragmented care and unintended consequences for Wyoming families.